Scottish BMA meeting endorses new GP contract

Scottish BMA meeting endorses new GP contract

December 5 2017 GPs have voted in favour of the proposed new contract for general practice in...

NHS England to press ahead with curbs on prescribing items with little evidence base

NHS England to press ahead with curbs on prescribing items with little evidence base

December 1 2017 The first group of products that which should no longer be ordinarily prescribed...

New primary care guidance for commissioners issued

New primary care guidance for commissioners issued

November 21 2017 NHS England has issued new guidance for commissioners around primary care. The...

Burns review recommends how targets and health indicators should be developed in Scotland

Burns review recommends how targets and health indicators should be developed in Scotland

November 21 2017 A Scottish health review in Scotland has set out key principles and...

Scotland’s ‘distinctively’ new GMS contract for 2018 is announced

Scotland’s ‘distinctively’ new GMS contract for 2018 is announced

November 16 2017 Scotland’s new General Medical Services contract could “reduce...

  • Scottish BMA meeting endorses new GP contract

    Scottish BMA meeting endorses new GP contract

    Tuesday, 05 December 2017 11:05
  • NHS England to press ahead with curbs on prescribing items with little evidence base

    NHS England to press ahead with curbs on prescribing items with little evidence base

    Friday, 01 December 2017 10:32
  • New primary care guidance for commissioners issued

    New primary care guidance for commissioners issued

    Tuesday, 21 November 2017 14:54
  • Burns review recommends how targets and health indicators should be developed in Scotland

    Burns review recommends how targets and health indicators should be developed in Scotland

    Tuesday, 21 November 2017 14:47
  • Scotland’s ‘distinctively’ new GMS contract for 2018 is announced

    Scotland’s ‘distinctively’ new GMS contract for 2018 is announced

    Thursday, 16 November 2017 18:16

a doctor in consultation imageDecember 1 2017

The first group of products that which should no longer be ordinarily prescribed on the NHS in England has been approved by the NHS England Board.

A consultation over the summer proposed limiting the prescribing of treatments of low value or effectiveness, and/or which can be purchased over the counter. Following its Board meeting on November 30, NHS England is now advising clinical commissioning groups and GPs that the following should no longer be routinely prescribed:

  • homeopathy – “no clear or robust evidence to support its use”;
  • herbal treatments – “no clear or robust evidence to support its use”;
  • omega-3 fatty acid compounds – “essential fatty acids which can be obtained through diet, low clinical effectiveness;
  • co-proxamol – it has had its marketing authorisation withdrawn due to safety concerns, no new pateints should be started on co-proxamol, and and it should be ‘deprescribed’ for existing patients;
  • rubefacients (excluding topical NSAIDS) – “limited evidence”;
  • lutein and antioxidants – used to treat the eye condition age related macular degeneration, “low clinical effectiveness”;
  • glucosamine and chondroitin – “low clinical effectiveness”.

NHS England will also commence a new detailed consultation in 2018 on which self-limiting conditions should be included in the programme to limit prescribing of OTC products. This could mean restrictions on prescribing paracetamol, cough mixture and cold treatments, eye drops, laxatives and sun cream lotions.

“The NHS could save around £190 million a year by cutting such prescriptions for minor, short-term conditions, many of which will cure themselves or cause no long-term effect on health,” said NHS England.

Dr Graham Jackson, NHSCC co-chair and clinical chair of NHS Aylesbury Vale CCG, said: “The guidance launched today, which resulted from work we initiated on behalf of our members, will support clinical commissioners in their work to prioritise effectively and make sure they are getting the best value for their medicines spend.

“We were pleased by the volume of responses to the consultation, which gave an opportunity to take into account and reflect the views of public, patients and clinicians and key stakeholders in the final guidance. We need to carry on having these honest open conversations on what the NHS can and should provide with the funding it has, so that we can continue to deliver high quality care.”

National Voices, the coalition of 160 health and care charities, has raised concerns regarding the proposed restrictions on prescribing OTC medicines. “This would include treatments dispensed to the millions of people who qualify for free prescriptions, such as those on Jobseeker’s Allowance or Employment and Support Allowance, older people, children, pregnant mothers, and people living with cancer,” it said.

Don Redding, Director of Policy at National Voices, added: “If taken forward, these plans could mean that some treatments are only available to those who can afford them. This would risk adversely affecting those people who currently get free prescriptions, which includes some of the most vulnerable in our society and those who are ‘just about managing’.

“Yes, there are difficult decisions for the NHS to make, but the rationing of treatments should not be targeted at those most in need, and those already living on a financial knife-edge.”

He said the organisation had “noted NHS England’s commitment to meaningfully engage patient groups to understand these unintended consequences and we look forward to working with them.”

Links:
NHS England announcement      
NHS England Board Paper setting out the proposals for the initial list and summarising consultation responses    
NHS England - Items which should not be routinely prescribed in primary care      
National Voices comment             

Contract News

December 13 2017 Women using hormonal contraceptives are exposed to a 20% increased risk of developing breast cancer, a 17-year-long study has shown. The relative risk is considered small, however,...
December 10 2015 A doctor may find themselves the subject of an investigation at any time in their career, from medical students to trainee doctors, GPs or consultants. Whether it’s an issue...